Health TrialsbyHealthPanel

Active Systemic Juvenile Idiopathic Arthritis

1

Review clinical trials related to Active Systemic Juvenile Idiopathic Arthritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

A multicenter, randomized Phase II/III clinical study to evaluate the efficacy and safety of GenaKumab in the treatment of active systemic juvenile idiopathic arthritis.

Participants needed: 290
Trial details
Age: 2-17Biological sex: AllType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Sep 17, 2026Locations: 10
Eligibility criteria

Male and female patients, with the remaining before age 2 years old or more and... [+2]

Pregnant or lactating female subjects [+5]

Read more